Why brain cancer?
It is estimated that over 1,900 Australians are diagnosed with brain cancer each year. While incidence rates of brain cancer are low compared to other cancer types, the mortality rate of this devastating disease is one of the highest.
Approximately 75% of patients diagnosed with the most aggressive brain cancer sub-type, glioblastoma, will not survive beyond 12 – 18 months.
Therapeutic interventions for brain cancer patients have not appreciably improved in decades. Despite the dedicated efforts of the neuro-oncology community within Australia and globally, clinical trials in brain cancer have largely failed.
We hope to change this.
Brain Cancer Disease Obstacles
Big problems to overcome.
Only modest advancements in the treatment of brain cancer is due to the complexity of this disease.
We face significant disease obstacles in the fight against brain cancer.
Better therapeutic treatment options can only be discovered through designing clinical trials that specifically address these historically persistent issues.
The Consortium for Neuro-Oncology Excellence (CNE) aims to combine forces to tackle each of these obstacles.